BSE filing, NSE: SYMBIOTEC. Summary written from the filing by ALFA Finder's alert engine.
Symbiotec Pharmalab Ltd: key numbers
- Share price
- ₹1,271.50
- Market cap
- ₹8,170 Cr
- Revenue (annual)
- ₹869.1 Cr
- Net profit (annual)
- ₹109.9 Cr
- Promoter holding
- 33.28%
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Symbiotec Pharmalab Ltd
All →Symbiotec Pharmalab Results Update
Symbiotec Pharmalab released its Q2 and H1 FY27 investor release, reporting consolidated Q2 revenue of ₹280 crore and PAT of ₹52 crore. The release also cites a ₹53 crore milestone revenue from a US licensing agreement.
Symbiotec Pharmalab Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹280 Cr (+43%), PAT ₹52 Cr (+169%); H1 revenue ₹498 Cr (+25%), PAT ₹66 Cr (+34%). Capex-led push into DCV injectables and CDMO.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing lists promoter and public holdings with no transaction or corporate event.
Symbiotec Pharmalab Board Meeting Date
Symbiotec Pharmalab schedules a 5 November 2026 board meeting to consider unaudited quarterly and half-year results. No amounts are proposed.
Symbiotec Pharmalab Share Pledge
Promoters of Symbiotec Pharmalab submitted a revised disclosure to update the lender and trustee names for their pledged share encumbrance.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31 of the SEBI LODR Regulations.
Other results update announcements
All →Inventurus Knowledge Solutions Results Update
IKS Health reported strong Q2 FY27 revenue and EBITDA growth year-on-year, with TruBridge integration adding scale. The release also highlighted new US healthcare customer wins.
Gokaldas Exports Results Update
Gokaldas Exports issued a press release on unaudited Q2 and H1 FY27 results, reporting consolidated total income of ₹1,135 crore (up 13% YoY) and EBITDA of ₹127 crore. The release includes a P&L highlights table with Total Income, EBITDA and PAT rows.
Prime Industries Results Update
Prime Industries released Q2 FY27 highlights: revenue ₹24.99 crore, PAT ₹6.62 crore. Figures come from unaudited consolidated results for the period ended September 30, 2026.
INDO SMC Results Update
Indo SMC reported H1FY27 total income up 94% to ₹218 crore and net profit up 76% year-on-year. The release also highlights an order book of ₹145 crore.
Safari Industries (India) Results Update
Safari Industries posted Q2FY27 revenue up 9.1% to ₹582.22 crore and PAT of ₹36.93 crore. It also approved capex of up to ₹230 crore for capacity expansion.
- combined production capacity
- 18.0 lakh pieces per month
ADF Foods Results Update
ADF Foods reported Q2 FY27 consolidated revenue of Rs 200.9 Cr, up 23.6% YoY. It also declared an interim dividend of 30% of face value.